Skip to main content
. 2022 Mar 3;16(2):128–145. doi: 10.1007/s13206-022-00052-5

Fig. 5.

Fig. 5

mRNA delivery systems formulated with peptide-derived and inorganic nanoparticles. a Pulmonary delivery of mRNA formulations with different transfection agents (naked mRNA, PEG-KL4/mRNA, and lipoplex/mRNA). At 24 h post-administration, the lungs were isolated for bioluminescence imaging, and luciferase protein expression of lung tissues were measured (Reproduced with permission from [1]

Copyright 2019, Journal of Controlled Release). b Graphical abstract of cell-penetrating peptide (CPP) PepFect 14 (PF14)-mRNA nanoparticles in models of ovarian cancer (Reproduced with permission from [67] Copyright 2019, European Journal of Pharmaceutics and Biopharmaceutics). c Illustration of the fully functionalized SeNP (Reproduced with permission from [74] Copyright 2021, Pharmaceutics). d Actual sizes of representative tumors after xenograft implantation followed by injection of 5 nM AuNP-αRNA I-5’BAX mRNA in mice (reproduced with permission from [75] Copyright 2013, PLOS ONE)